POSTOPERATIVE PREVENTIVE TREATMENT OF CROHN'S DISEASE (review)

[1]  M. Regueiro,et al.  Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. , 2016, Gastroenterology.

[2]  M. Regueiro,et al.  A Practical Approach to Preventing Postoperative Recurrence in Crohn’s Disease , 2016, Current Gastroenterology Reports.

[3]  Steven J Brown,et al.  Crohn's disease management after intestinal resection: a randomised trial , 2015, The Lancet.

[4]  M. Regueiro,et al.  Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  Koji Tanaka,et al.  The impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn’s disease: a single-center paired case–control study , 2014, Surgery Today.

[6]  L. Guidi,et al.  Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. , 2013, Journal of Crohn's & colitis.

[7]  Toshiaki Watanabe,et al.  Strategies for the prevention of postoperative recurrence of Crohn's disease , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[8]  E. Savarino,et al.  Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial , 2013, The American Journal of Gastroenterology.

[9]  D. Sorrentino.  State-of-the-art medical prevention of postoperative recurrence of Crohn's disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[10]  Christopher F. Martin,et al.  Ciprofloxacin for prevention of postoperative recurrence in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled pilot study , 2015 .

[11]  G. Mantzaris,et al.  Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. , 2012, Journal of Crohn's & colitis.

[12]  A. Zinsmeister,et al.  Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970–2004) , 2012, The American Journal of Gastroenterology.

[13]  Jana G Hashash,et al.  The evolving management of postoperative Crohn’s disease , 2012, Expert review of gastroenterology & hepatology.

[14]  C. Sánchez-Montes,et al.  Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. , 2012, World journal of gastroenterology.

[15]  H. Ogata,et al.  The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study , 2012, International Journal of Colorectal Disease.

[16]  M. Regueiro,et al.  Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease , 2011, Digestive Diseases and Sciences.

[17]  P. Moayyedi,et al.  5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.

[18]  M. Regueiro,et al.  Preventive therapy in postoperative Crohn's disease , 2010, Current opinion in gastroenterology.

[19]  M. Geraci,et al.  Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  A. Cheifetz,et al.  Interventions for prevention of post-operative recurrence of Crohn's disease. , 2009, The Cochrane database of systematic reviews.

[21]  S. Hanauer,et al.  Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis , 2009, The American Journal of Gastroenterology.

[22]  M. Regueiro,et al.  Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.

[23]  P. Tekkis,et al.  The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies , 2008, International Journal of Colorectal Disease.

[24]  J. Terdiman.  Prevention of postoperative recurrence in Crohn's disease. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  S. Ng,et al.  Management of Postoperative Crohn's Disease , 2008, The American Journal of Gastroenterology.

[26]  A. Darzi,et al.  A Meta-Analysis Comparing Incidence of Recurrence and Indication for Reoperation After Surgery for Perforating Versus Nonperforating Crohn's Disease , 2008, The American Journal of Gastroenterology.

[27]  C. Avellini,et al.  Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. , 2007, Archives of internal medicine.

[28]  C. Avellini,et al.  Prevention of postoperative recurrence of Crohn's disease by infliximab. , 2006, European journal of gastroenterology & hepatology.

[29]  Takayuki Yamamoto.  Factors affecting recurrence after surgery for Crohn's disease. , 2005, World journal of gastroenterology.

[30]  P. Rutgeerts,et al.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. , 2005, Gastroenterology.

[31]  S. Kane,et al.  Tobacco Use Is Associated With Accelerated Clinical Recurrence of Crohn's Disease After Surgically Induced Remission , 2005, Journal of clinical gastroenterology.

[32]  A. Taschieri,et al.  Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. , 2004, Gastroenterology.

[33]  R. Thisted,et al.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. , 2004, Gastroenterology.

[34]  A. Griffiths,et al.  Corticosteroids for maintenance of remission in Crohn's disease. , 2003, The Cochrane database of systematic reviews.

[35]  T. Junginger,et al.  The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease. , 2001, Hepato-gastroenterology.

[36]  G. Hellers,et al.  Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease , 2000, The British journal of surgery.

[37]  O Bernell,et al.  Risk factors for surgery and postoperative recurrence in Crohn's disease. , 2000, Annals of surgery.

[38]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[39]  Z. Cohen,et al.  Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. , 1995, Gastroenterology.

[40]  P. Rutgeerts,et al.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. , 1995, Gastroenterology.

[41]  T. Balestracci,et al.  Primary and recurrent Crohn's disease. Experience with 1379 patients. , 1991, Annals of surgery.

[42]  R. Modigliani,et al.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. , 1990, Gastroenterology.

[43]  C. Herfarth,et al.  Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. , 1989, Digestion.

[44]  D. Sachar,et al.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. , 1988, Gut.

[45]  L. Melton,et al.  Surgical history of Crohn's disease in a well-defined population. , 1982, Mayo Clinic proceedings.

[46]  G. Hellers.  Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. , 1979, Acta chirurgica Scandinavica. Supplementum.